Financial News
This biotech start-up is working overtime to develop a second-wave, mutation-resistant Covid-19 vaccine
March 29, 2021 at 10:29 AM EDT
Hannu Rajaniemi, the co-founder and CEO of Helix Nanotechnologies, has spent the last year racing to come up with a mutation-resistant Covid-19 vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
